Incidence of Hyponatremia in PEG-SD Compared to PEG-ELS
- Conditions
- Hyponatremia
- Interventions
- Drug: PEG-ELSDrug: PEG-SD
- Registration Number
- NCT01299779
- Lead Sponsor
- Thomas Jefferson University
- Brief Summary
Objective: To compare the incidence of peri-colonoscopy hyponatremia associated with PEG 3350 + sports drink (PEG-SD) versus PEG 3350-electrolyte solution + sodium sulfate + sodium ascorbate and ascorbic acid (PEG-ELS).
Hypothesis: As compared to PEG-SD, hyponatremia occurs significantly less often with PEG-ELS.
- Detailed Description
Looking at the Incidence of Hyponatremia With Two Commonly Prescribed Purgatives for Colonoscopy-Polyethylene Glycol 3350 With a Sports Drink (PEG-SD) Compared to Polyethylene Glycol 3350 With Electrolyte Solution (PEG-ELS)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 460
- Adults age 18 years or older scheduled for elective outpatient colonoscopy: 8am - noon.
-
Unable or unwilling to consent
-
Pregnant
-
Breast feeding
-
Significant psychiatric illness
-> 50% colon resection
-
Bowel obstruction
-
History of hyponatremia (Serum sodium <135 mmol/L)
-
End stage renal disease on dialysis
-
History of chronic kidney disease (other than kidney stones)
-
Decompensated cirrhosis, including:
- History of bleeding due to portal hypertension (varices, gastropathy, etc) within 3 months
-
Hepatic encephalopathy (not controlled with medications) within 3 months
-
Clinical presence of ascites
-
Active cardiac disease
-
Recent myocardial infarction (<4weeks)
-
Unstable angina
-
Congestive heart failure NYHA Functional Class Stage III or IV
-
Stage III: Marked limitation of activity. Less than ordinary activity (e.g. walking short distances, 20-100 m) causes fatigue, palpitations, dyspnea. Comfortable at rest.
-
Stage IV: Severe limitations. Experiences symptoms even while at rest. Mostly bedbound patients.
Exclusion Criteria (post-enrollment), from baseline labs:
- Serum creatinine > 1.5 mg/dL
- Serum potassium < 3.3 or > 5.5 mmol/L
- Serum sodium < 135 mmol/L or >150 mmol/L
- Serum calcium < 8.0 or > 11.0 mg/dL
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description PEG-ELS PEG-ELS - PEG-SD PEG-SD -
- Primary Outcome Measures
Name Time Method Development of hyponatremia in the peri-colonoscopy period blood drawn 30 minutes post colonoscopy
- Secondary Outcome Measures
Name Time Method Development of serum electrolytes levels outside the normal range for blood drawn 30 minutes post colonoscopy Sodium, chloride, potassium, calcium
Change from baseline for serum electrolytes blood drawn 30 minutes post colonoscopy Sodium, chloride, potassium, calcium
Change in renal function from baseline blood drawn pre colonoscopy and 30 minutes post colonoscopy Creatinine, calculated GFR
Changes in the following from baseline a. Serum vasopressin b. Serum osmolality c. Urine electrolytes and osmolality blood drawn pre colonoscopy and 30 minutes post colonoscopy Serum cortisol and TSH levels for only patients who develop hyponatremia blood drawn 30 minutes post colonoscopy Hemodynamic/volume changes at baseline and immediately prior to colonoscopy hemodynamic measurments taken pre and post colonoscopy * Weight
* Blood pressure supine and upright - systolic, diastolic
* Pulse supine and upright
* Development of orthostatic change: yes/no
* Development of orthostatic symptoms - light-headed, dizzy, diaphoretic, etc.: yes/noAdverse Events - Incidence and severity using 10-point Likert scale 1 hour post colonoscopy assessment * GI - nausea, vomiting, abdominal pain, bloating
* Light headednessPrep Completion: <90% vs. > 90% one time assessment pre colonoscopy Indication for colonoscopy: Screen/Surveillance vs. Symptom one time assessment pre colonoscopy Assessment of independent risk factors for hyponatremia one time assessment pre colonoscopy * Age
* Sex
* Race
* Medications
* Medical history
* BMI
* Anxiety - Beck scale
* Fluid intake for 24 hours prior to colonoscopy (not including the prep or fluids required to accompany the prep); patients will be shown a liter container to assist with their estimate.
i. Less than 3 Liters ii. 3-5 liters iii. More than 5 litersEfficacy endoscopist will evaluate during colonoscopy * Whole colon prep: adequate (excellent/good) vs. inadequate (fair/poor)
* Cecal or small bowel intubation - Yes/No
Trial Locations
- Locations (1)
Thomas Jefferson University
🇺🇸Philadelphia, Pennsylvania, United States